Vitrolife: New Vice President


STOCKHOLM, Sweden, May 19, 2005 (PRIMEZONE) -- Christer de Flon has been appointed Director of Global Sales and Marketing and at the same time also Vice President of Vitrolife.

In line with the strategy of expanding Vitrolife's sales organization and thereby direct contact with the customers, Christer de Flon has been appointed Director of Global Sales and Marketing. This means that all personnel within marketing and sales in the Vitrolife Group will be led by de Flon, via a marketing director and two regional sales directors, one for South and North America and one for Europe and Asia. At the same time de Flon has also been appointed company Vice President.

Since February this year Christer de Flon has worked as Vitrolife's sales director. Christer has many years of experience in senior management within the pharmaceuticals industry, amongst other things as the head of marketing at Astra Zeneca in Sweden and as the CEO at Carlsson Research AB.

Magnus Nilsson CEO

Vitrolife is a global biotechnology/medical device Group that works with developing, manufacturing and selling advanced products and systems for the preparation, cultivation and storage of human cells, tissue and organs. The company has business activities within three product areas: Fertility, Transplantation and Cell therapy. The Fertility product area works with nutrient solutions (media) for the treatment of human infertility. The Transplantation product area works with solutions and systems to maintain tissue in optimal condition outside the body for the required time while waiting for transplantation. The Cell therapy product area works with media to enable the use of stem cells for therapeutic purposes.

Vitrolife today has over 80 employees and the company's products are sold in more than 80 markets. The head office is in Kungsbacka, Sweden, and there is a subsidiary in Denver, USA. The Vitrolife share is listed on the O-list of the Stockholm Stock Exchange.

Vitrolife AB (publ), Faktorvagen 13, SE-434 37 Kungsbacka, Sweden. Corporate identity number 556354-3452. Tel: +46 31 721 80 00. Fax: +46 31 721 80 90. E-mail: info@vitrolife.com. Homepage: www.vitrolife.com.

This information was brought to you by Waymaker http://www.waymaker.net

The following files are available for download:

http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=99939&fn=wkr0001.pdf


            

Contact Data